JP Morgan analyst Daniel Wolle maintains Immunogen (NASDAQ:IMGN) with a Neutral and raises the price target from $8 to $9.
Disney Provides First Look At More Disney+ Animated Series: What Investors Should Know
Media giant Walt Disney Co (NYSE: DIS) is using the Annecy International Animation Film Festival to highlight upcoming new animated series that will hit Disney+ and other Disney platforms in 2023. Here’s a look at what was unveiled.
